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constituents of the immune system. These cells often mediate their effects through the production of
immunosuppressive factors. At present our understanding of how these cells are generated is limited. Here
we report the presence of a population of IL-10-producing, virus-speciﬁc CD8+ T cells in the lungs of mice
following acute respiratory infection. These cells were only found at minimal levels in the spleen and
draining lymph node; instead they were restricted primarily to the infected lung tissue. A major ﬁnding from
this study is demonstration that the ability to produce IL-10 can be acquired by IFNγ-producing effector cells
following entry into the infected lung. These studies suggest IL-10 production is the result of further
differentiation of an antigen-speciﬁc CD8+T cell that is governed by signals present in infected lung tissue.spiratory syncytial virus; MLN,
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Themucosal surfaces of the body face anonslaught of environmental
challenges every day. These sites are often characterized by the
generation of tolerogenic immune responses (Izcue et al., 2006;
Lefrancois and Puddington, 2006). The lung is one suchmucosal surface
that must balance responses to pathogens and particulate matter with
the appropriate mix of pro- and anti-inﬂammatory mediators. The
balance of these competing effects determines whether a pathogenwill
ﬂourish in its host or be eliminated as well as whether the immune
response will mediate unnecessary tissue damage.
Regulatory T cells (Tregs) contribute to the balance of an immune
response by dampening the activity of T cells. They exert this effect by
immunosuppressive cell–cell contact and the secretion of cytokines, e.g.
IL-10 and TGFβ (Sakaguchi et al., 1995; Mills, 2004; Bluestone and
Abbas, 2003; Von Herrath and Harrison, 2003). While regulatory
function has been best characterized in CD4+ T cells (Bluestone and
Abbas, 2003; Shevach, 2006; O'Garra and Vieira, 2004), recently TGFβ
and/or IL-10-producing CD8+ T regulatory cells have been reported
(Noble et al., 2006; Myers et al., 2005; Gilliet and Liu, 2002). The
mechanism responsible for the suppression mediated by these cells
appears diverse. For example in a study by Gilliet and Liu (2002), the
production of IL-10 was directly responsible for the suppressive effects.
However, a report from Myers et al. suggested TGFβ could mediate
suppression (Holt et al., 1993; Myers et al., 2005). In other studies
suppression has been reported to be independent of a soluble factor andinstead required direct cell–cell contact (Noble et al., 2006). Whether
thesevariedmechanisms reﬂect differences in the typeof regulatory cell
generated remains to be determined. While pathogen-speciﬁc, CD8+
cells capable of producing IL-10 have been found in a number of chronic
and acute infection models (Belkaid et al., 2001; Accapezzato et al.,
2004; Spender et al., 1998; Sun et al., 2009), the signals that are
responsible for their generation are relatively undeﬁned.
Our laboratory studies respiratory tract infection using the para-
myxovirus simian virus 5 (SV5) as a model. SV5 infection results in the
generation of a CD8+ T cell response that is responsible for clearance of
virus (Young et al., 1990). Given the immunosuppressive environment
of the lung, we have tested whether residence of effector cells in the
lungs resulted in altered function. Our previous results have shown that
over time, virus-speciﬁc effector cells CD8+ T cells in the lung, but not
other organs, become increasingly nonfunctional (Gray et al., 2003),
suggesting that the lung environment may further modify CD8+ T cell
effector function. Here we investigated whether residence in the lung
resulted in additional changes in virus-speciﬁc cells. We found that a
portion of effector cells co-produced IL-10 in addition to IFNγ. IL-10
production was mainly limited to cells present in the lungs and was
dependent on virus infection of this tissue. Further our data support a
model wherein the ability to produce IL-10 can be acquired by effector
cells following entry into the infected lung. These ﬁndings provide new
insights into the generation of CD8+ IL-10-producing effector cells.
Results
Virus-speciﬁc CD8+ IL-10-producing cells are found in the lungs, but not
MLN, spleen or peripheral blood following intranasal infection with SV5
We examined whether IL-10-producing cells were generated
following infection of the lung with the paramyxovirus SV5. On day
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lymph node (MLN), or spleen (Fig. 1B) of SV5 infected mice and
stimulated with the immunodominant M285–293 peptide. Results from
the lungs of mock-infected animals are shown for comparison in
Fig. 1A. Peptide-stimulated production of IFNγ and IL-10 was
measured by intracellular staining. IFNγ-producing cells were readily
apparent in CD8+ T cells isolated from the MLN, spleen, and lung.
However, IL-10-producing cells were only detected in the lung, with
on average approximately 7% of IFNγ+ cells co-producing IL-10
(Fig. 1C). Of note, IL-10-producing cells were found exclusively among
the IFNγ-producing population and interestingly were among the
higher IFNγ producers (MFI of IFNγ+IL-10+ cells=289±12, MFI of
IFNγ+IL-10− cells=173±19, p=0.007).Fig. 1. CD8+IFNγ+IL-10+ SV5-speciﬁc cells are detected only in the lungs of
intranasally infected mice. A) Mice were intranasally infected with SV5. On the
designated day, tissues were harvested and CD8+ T cell function assessed by ICCS. An
isotype control antibody for IL-10 staining was used to ensure speciﬁcity for the
detection of IL-10-producing cells. Plots shown were gated on live, CD8+ T cells. Lung
cells were isolated from naïve mice or mice infected with SV5 12 days prior. Isolated
cells were cultured in the presence of theM peptide (1 µM) for 5 h, followed by staining
for IFNγ and IL-10. Numbers shown in plots are the percentages of IFNγ-producing cells
that also produce IL-10. B) MLN and spleen cells were harvested on d12 p.i. following
infection with SV5. Cells were restimulated in the presence of M peptide and IFNγ and
IL-10 production determined by ICCS. Data are presented as in A. C) Averaged data from
lungs cells of mice d12 p.i. with SV5 or SV5-gp160 following stimulation in the presence
of M or I10 peptides (1 µM). Averaged data are from at least 5 mice.To determine whether IL-10 production was unique to CD8+ T
cells that recognized the M epitope, mice were infected with a
recombinant SV5 that expressed the HIVgp160 envelope (SV5-
gp160). The immunodominant epitope identiﬁed from gp160,
designated I10, encompasses residues 318–327 (Kozlowski et al.,
1992). As was observed for the M285–293-speciﬁc cells, a portion of the
I10-speciﬁc CD8+ T cells in the lung made IL-10 in addition to IFNγ
(Fig. 1C). CD8+IFNγ+IL-10+ cells present in the respiratory tract were
detected in the airway (isolated by BAL) as well as the tissue resident
populations (data not shown).
Kinetic analysis for the presence of IL-10-producing cells in the lung
Tobetter deﬁne the emergence of IL-10-producing cells in the lung, a
kinetic study was performed. It was possible that the occurrence of IL-
10-producing cells in the lungmirrored the presence of IFNγ-producing
effector cells. Alternatively these two cell populations may have arisen
with distinct kinetics. This analysis showed that SV5-speciﬁc IFNγ-
producingeffectorswere readily detected in the lungatd7p.i., peaked in
number at d12, andwere reduced by d20 (Fig. 2A). Our previous studies
have shown that prior to d7, very few SV5-speciﬁc CD8+ T cells are
present in the lung ((Gray et al., 2003) and our unpublished data). As a
percentage of IFNγ-producing cells, IL-10-producing cells were maxi-
mal at d7 p.i. (Fig. 2B). This time correlatedwith the period of high viral
burden in the lung (Fig. 2C). However, while the percentage of M-
speciﬁc cells that produced IL-10 decreased between days 7 and 12,
there was a large increase in the total number of IFNγ-producing, M-
speciﬁc cells present in the lung during this period (Fig. 2A). This
resulted in an increase in the absolute number of IL-10-producing cells
(Fig. 2D). Thus as a percentage, IL-10-producing cells peakedwhen virus
burden in the lung was high.
Respiratory infection is required for the induction of IL-10-producing
SV5-speciﬁc CD8+ T cells
Our observation that CD8+IFNγ+IL-10+ cells were detected only
in the lungs of SV5-infected mice led us to ask whether it was the
presence of infection or simply the lung environment that determined
IL-10 production by CD8+ T cells. To address this question, BALB/c
mice were infected with 106 PFU of SV5 by the intranasal or
intraperitoneal route. Following i.n. infection, SV5 could be readily
detected in the lung; however, virus was limited to the lung and was
not detected in the spleen (Table 1). Likewise, virus was not detected
in either the lung or spleen following i.p. administration. Thus the
only condition under which infectious virus could be detected was in
the lung following intranasal infection.
To determine whether cells present in lungs following infection by
the i.p. route also produced IL-10, lung and spleen cells were isolated
on d12 postinfection and cultured in the presence of M peptide.
Importantly IFNγ-producing, M-speciﬁc cells were detected in the
lung and the spleen regardless of the route of infection (Fig. 3A and B,
respectively). However, IL-10-producing CD8+ T cells were detected
at signiﬁcant levels only in the lungs of intranasally infected mice
(Fig. 3A). These results suggested that respiratory infection was a
prerequisite for the generation of IL-10-producing cells in the lung.
The ability to produce IL-10 is acquired following entry of IFNγ+IL-10− cells
into the infected lung environment
The previous results suggested a hypothesis wherein the environ-
ment of the infected lung was responsible for the induction of IL-10-
producing cells. We postulated that the presence of these cells could
be the result of either their activation within the lung (i.e. in the BALT)
or the acquisition of the ability to produce IL-10 following entry into
the infected lung. To distinguish between the two possibilities, we
tested whether virus-speciﬁc cells that were capable of producing
Fig. 2. The number, but not the frequency of SV5 speciﬁc CD8+IFNγ+IL-10+ T cells present in the lungs correlates with the number of IFNγ+IL-10− cells. A) Lung lymphocytes were
harvested on the indicated days following intranasal infectionwith SV5. Lung cells were stimulated in the presence ofM peptide and stained for IFNγ. From these data the total number of
IFNγ-producing cells was determined. Averaged results (mean with SEM) are shown (n≥3). B) The percentage of CD8+IFNγ+ that co-produce IL-10+ cells between d7 and d48
postinfection was determined. C) On days 4-12 postinfection, lungs were harvested and the presence of SV5 virus determined by plaque assay. D) The number of CD8+IFNγ+ that co-
produce IL-10+ cells between d7 and d48 postinfection was determined. Averaged results (mean with SEM) are shown (n≥3).
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the lung. Splenocytes were isolated on day 6 following intravenous
infection with SV5. This route was chosen as it yielded the largest
percentage of IFNγ-producing cells. At this time, virtually no M-
speciﬁc cells produced IL-10 (similar percentage in the IL-10+
quadrant with anti-IL-10 antibody or isotype control antibody,
Fig. 4A). We did see low levels of IL-10 production in splenocytes in
some experiments; however this was always highly reduced
compared to what was observed in the lung resident populations
(data not shown). The remainder of the splenocytes was labeled with
CFSE. Labeled cells were transferred into recipient BALB/c mice that
had been intranasally infected with SV5 six days prior. Thus
transferred cells should be exposed to the same environment
encountered by M-speciﬁc cells when they ﬁrst enter the lung.
Twenty-two hours post-transfer, lung cells were isolated, stimulated
with M peptide, and IFNγ and IL-10 production determined. Our
results show a statistically signiﬁcant increase in the percentage of
CFSE+CD8+ T cells (the adoptively transferred population) that could
produce IL-10 (Fig. 4B, upper row). As expected the endogenous M-
speciﬁc effector cells (CD8+CFSE−) also contained a population of IL-
10-producing cells (Fig. 4B, lower row). Data in Fig. 4C show averaged
data for IL-10 production within the CFSE+ IFNγ-producing cells in
mice that received cells from donors that were infected with SV5 by
the i.n. or i.p. route. Together these results strongly support theTable 1
Virus titers from organs following i.n. or i.p. infection.
Day 4 Day 7
Lung Spleen Lung Spleen
i.n. 4.2×103 ± 1.3 ND⁎ 0.7×103±0.3 ND
i.p ND ND ND ND
⁎ ND=none detected.hypothesis that the ability to produce IL-10 can be acquired following
effector cell entry into the infected lung.
Discussion
Immunoregulation of effector T cells at the site of infection has the
potential to profoundly affect viral clearance. In models of chronic
infections, e.g. HIV, HCV, and Leishmania, CD4+ and CD8+ T cells have
been reported to secrete the immunosuppressive cytokine IL-10
(Belkaid et al., 2001; Accapezzato et al., 2004; Elrefaei et al., 2006;
Trinchieri, 2001). It has been suggested that under conditions of
chronic infection, such cells may limit tissue damage associatedwith a
persistent inﬂammatory state; however, they run the risk of
decreasing the ability of the immune system to clear the pathogen
(Trinchieri, 2001). The presence of IL-10-producing cells has also been
reported in the context of infection with inﬂuenza virus and RSV
(Spender et al., 1998; Sun et al., 2009).
The data presented in this paper provide evidence that a subset of
virus-speciﬁc, IFNγ-producing CD8+ effector cells found in the lung
following acute respiratory infection with the paramyxovirus SV5
produces IL-10. The presence of IL-10+IFNγ+SV5-speciﬁc effectors
was limited almost exclusively to the lung, i.e. these cells were only
minimally detected in the spleen or draining lymph node. Thus the
presence of these cells is coincident with sites of viral replication. In
support of this, respiratory infection was a prerequisite for the
generation of these cells as evidenced by the lack of IL-10 production
in cells in the virus-speciﬁc CD8+ T cells that reached the lung
following i.p. infection of SV5.
Our ﬁndings led us to test the hypothesis that the entry of IFNγ-
producing cells into the infected/inﬂamed lung environment resulted
in acquisition of IL-10-producing capabilities in a subset of effector
cells. To this end, CFSE-labeled cells from the spleens of mice that
were intraperitoneally infected with SV5 were transferred into the
lungs of SV5 infected recipients. At the time of transfer very few, if any
cells produced IL-10. The results from these studies showed that cells
Fig. 3. Respiratory infection is required for the induction of IL-10-producing SV5-
speciﬁc CD8+ T cells. Lung lymphocytes (A) and splenocytes (B) from mice infected
with SV5 by the intraperitoneal or intranasal route were harvested on day 12 following
infection. Cells were stimulated in the presence of M peptide and stained for the
presence of IFNγ and IL-10. Plots shown are gated on live, CD8+ T cells. Numbers shown
in the plots are the percentage of IFNγ-producing cells that produce IL-10. C) Mean
percentage (±SEM) of IFNγ-producing cells that co-produce IL-10 is shown. Values are
calculated following subtraction of staining obtained with isotype control antibody.
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infected lung. These are the ﬁrst data to show that this regulatory
function can be acquired by effector cells as a result of entry into the
infected tissue. Previous studies with inﬂuenza virus reported the
presence of these cells at signiﬁcant levels in draining lymph node
(Sun et al., 2009), making it unclear whether IL-10-producing cells
were preferentially expanding in the lungs following generation in
the lymph node or whether cells could acquire this ability upon entry
into this tissue. Further our studies show that the signal responsible
for altering the function of effector T cells in the lung is present only in
the context of infection.
Infection with pathogens that cause chronic infections is often
associated with the induction of IL-10-producing T cells (Mills, 2004)
as is infection with inﬂuenza virus (Sun et al., 2009). These ﬁndings
suggest that the inﬂammatory environment generated under such
circumstances may play a role in the induction of IL-10-producing Tcells. Such a model would be in agreement with our ﬁnding that the
highest percentage of IL-10-producing cells occurred at the peak of
virus burden in the lung. Presumably inﬂammation induced as a result
of infection would be highest when viral load is at its peak. However,
it is worth noting that infection with SV5 results in limited
inﬂammation in the lungs of mice, even at the peak of infection
(our unpublished data). Thus generation of IL-10-producing CD8+
effector cells is not dependent on infections that are highly
inﬂammatory or pathogenic (as is the case for inﬂuenza virus).
It has been reported that plasmacytoidDC in vitro can induceCD4+T
cells which co-produce IL-10 and IFNγ (Kadowaki et al., 2000;
Kawamura et al., 2006). It is possible that CD8+ T cell effector function
is similarly inﬂuenced by lung PDC in the context of respiratory tract
infection. Further characterization of DC populations in SV5 infected
mice is necessary to discern the role, if any, of PDC in our model system.
In summary, we have established that the lung environment
induced by respiratory infection with the paramyxovirus SV5
promotes the generation of IL-10-producing, virus-speciﬁc CD8+
effector T cells. A major ﬁnding from our work is the demonstration
that non-IL-10-producing cells can acquire this capacity relatively
quickly as a result of entry into the infected lung environment. Further
we demonstrate that this induction of IL-10 production is dependent
on ongoing infection in the lung. Thus it is not a basal property of this
tissue. Further study of the function of these cells and the factors that
contribute to their generation will continue to increase our under-
standing of the balance required for effective lung immune responses.
Materials and methods
Mice
BALB/c mice were purchased from the Frederick Cancer Research
and Development Center (Frederick, MD). All experiments in this
study comply with the institutional guidelines approved by the Wake
Forest University Animal Care and Usage Committee.
Peptides
SV5 M285–293 (Gray et al., 2003) and HIVgp160 I10 (RGPGRAFVTI)
(Takahashi et al., 1988) peptides were synthesized at the Compre-
hensive Cancer Center Protein Analysis Core Laboratory at Wake
Forest University School of Medicine.
Recombinant viruses
Wild-type recombinant SV5 (SV5) and SV5 expressing the HIV
protein gp160 (SV5-gp160) were generated using a reverse genetics
system from an infectious cDNA clone as described previously (Parks
et al., 2001).
Infection with recombinant viruses
Mice were anesthetized by i.p. injection with 2,2,2-tribromoetha-
nol (Avertin). Anesthetized mice received 1×106 plaque forming
units (PFU) of SV5 or SV5-gp160 intranasally (i.n.) in 50 µl PBS. Mice
were euthanized at the indicated timepoints and MLN, spleen,
peripheral blood and lungs were harvested.
Cell culture, surface and intracellular cytokine staining
Lymphocytes isolated from the lung, spleen, MLN, or peripheral
blood were cultured for 5 h in 96-well ﬂat-bottomed plates in a
volume of 200 µl of complete medium (RPMI 1640 containing 10%
fetal calf serum, 100 units/ml penicillin, 100 µg/ml streptomycin,
2 mM L-glutamine, 10 µM HEPES, 1 mM sodium pyruvate, 1× non-
essential amino acid mixture and 5×10−5 M 2-ME) in the presence
Fig. 4. The ability to produce IL-10 can be acquired by CD8+IFNγ+ cells following entry into the lungs of infected mice. A) BALB/c mice were infected i.v. with SV5. On day 6 p.i.,
splenocytes were isolated and stimulated with M peptide to ensure that the cells for transfer produced IFNγ but not IL-10. The remaining day 6 splenocytes were labeled with 5 mM
CFSE and transferred intravenously into recipient mice that had been intranasally infected with SV5 6 days prior. Twenty-two hours post-transfer of CFSE-labeled cells, recipients
were euthanized and lung cells isolated. IFNγ and IL-10 production in cells was assessed following restimulation with M peptide. Adoptively transferred cells were identiﬁed by
gating on CD8+CFSE+ cells and endogenous responding cells by gating on CD8+CFSE− cells. The percentage of transferred CD8+ T cells present in the lung that make IL-10 in
response to M peptide stimulation was calculated (n=6). Representative data from lung cells are shown in (B) and averaged data are shown in (C). The data in (C) also include the
percentage of cells that were capable of producing IL-10 following transfer into recipient mice that were intraperitoneally infected with SV5. These served as a control for the
requirement for SV5 infection in the lung for induction of IL-10 production in cells.
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out in the presence or absence of 1 µM or otherwise indicated
concentrations of M285–293 peptide. All antibodies were purchased
from BD PharMingen. Cells were stained with anti-CD8alpha-
PerCPCy5.5 (clone 53-6.7). Cells were permeabilized using the
Cytoﬁx/Cytoperm kit according to the manufacturer's instructions
(BD PharMingen, San Diego, CA). Intracellular IFNγwas detected with
rat anti-mouse IFNγ-FITC or -PE (clone XMG 1.2). Intracellular IL-10
was detected with rat anti-IL-10-APC (clone JES5-16E3) or APC-
conjugated isotype control. Samples were ﬁxed in 2% paraformalde-
hyde. Stained samples were run on a BD Biosciences FACSCalibur ﬂow
cytometer and data were analyzed using CellQuest software (BD
Immunocytometry Systems, San Jose, CA).
Adoptive transfer of spleen derived M-speciﬁc cells
BALB/c mice were intravenously or intraperitoneally infected with
SV5 (106 or 108 PFU respectively). On day 6 p.i., splenocytes were
isolated and a portion stimulated with M peptide (1 µM) to assess
baseline production of IL-10. The remaining day 6 splenocytes were
labeled with 5 µM CFSE and 3.8×107 cells were transferred
intravenously into recipient mice that had been intranasally infected
with SV5 (1×106 PFU) six days prior. Twenty-two hours post-transfer, lung cells were isolated and restimulated with 1 µM peptide
to determine IL-10 and IFNγ production in CFSE+ (transferred cells)
and CFSE− (endogenously responding cells) populations.
SV5 plaque assay
Lungs and spleens collected from mice at the indicated day post
infection were frozen and stored at −80 °C until homogenization.
Lungs were homogenized with PowerGen 700 homogenizer (Fisher
Scientiﬁc) in 1 ml DMEM containing 0.75% BSA and 10 mM Hepes.
Diluted lung homogenates were incubated with a conﬂuent layer of
CV-1 (derived from African green monkey kidney) cells for 1–2 h at
37 °C. After removal of homogenate and 1×wash with PBS, CV-1 cells
were overlaid with DMEM containing 1% agar noble, 2% fetal calf
serum, 2 mM L-glutamine and Hepes, pH 7.2. Inverted plates were
incubated at 37 °C for 5 days. To enumerate PFU, cell monolayers were
ﬁxed with 3.7% formaldehyde in water and stained with crystal violet.
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